Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer
· persica pharmaceuticals
AI Briefing
- Persica Pharmaceuticals appoints Dr. Edward Littler as Executive Chairman, David Watson as CEO, marking a significant boost to the company's biopharma development
- The appointments bring extensive industry experience to the board and leadership team
- Persica moves into its next phase of growth and development with its new senior executives
Advertisement